ATP8B1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 4.53100001962525E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
3.10469999709184E-08 |
Normal-vs-Stage2 |
1.17210000039059E-07 |
Normal-vs-Stage3 |
2.52770004927072E-09 |
Normal-vs-Stage4 |
8.96179999987368E-07 |
Stage1-vs-Stage2 |
2.219800E-01 |
Stage1-vs-Stage3 |
1.004360E-01 |
Stage1-vs-Stage4 |
8.441600E-02 |
Stage2-vs-Stage3 |
8.375400E-01 |
Stage2-vs-Stage4 |
5.912600E-01 |
Stage3-vs-Stage4 |
6.925200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.78009995632777E-09 |
Normal-vs-AfricanAmerican |
6.2254999999567E-07 |
Normal-vs-Asian |
7.175500E-03 |
Caucasian-vs-AfricanAmerican |
6.067600E-01 |
Caucasian-vs-Asian |
8.746800E-01 |
AfricanAmerican-vs-Asian |
9.814000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.26518803714271E-12 |
Normal-vs-Female |
1.120360E-02 |
Male-vs-Female |
2.503400E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
1.296260E-03 |
Normal-vs-Extreme_Weight |
3.72530006842453E-10 |
Normal-vs-Obese |
2.58910004546919E-09 |
Normal-vs-Extreme_Obese |
1.97770000043285E-07 |
Normal_Weight-vs-Extreme_Weight |
2.609600E-01 |
Normal_Weight-vs-Obese |
3.265600E-01 |
Normal_Weight-vs-Extreme_Obese |
3.354000E-02 |
Extreme_Weight-vs-Obese |
8.210200E-01 |
Extreme_Weight-vs-Extreme_Obese |
8.524200E-02 |
Obese-vs-Extreme_Obese |
1.943040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.36389999999087E-05 |
Normal-vs-Age(41-60Yrs) |
1.25150000029883E-07 |
Normal-vs-Age(61-80Yrs) |
6.82869982782108E-10 |
Normal-vs-Age(81-100Yrs) |
4.99329999570364E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.971600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.651200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.988770E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.414830E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.395900E-03 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.753600E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
1.12800002671776E-09 |
Normal-VS-Type2 PRCC |
5.88418203051333E-12 |
Normal-VS-KIRP CIMP |
1.062390E-02 |
Normal-VS-Unclassified PRCC |
1.30590000002595E-06 |
Type1 PRCC-VS-Type2 PRCC |
2.700400E-02 |
Type1 PRCC-VS-KIRP CIMP |
2.612600E-01 |
Type1 PRCC-VS-Unclassified PRCC |
5.082600E-01 |
Type2 PRCC-VS-KIRP CIMP |
3.740200E-02 |
Type2 PRCC-VS-Unclassified PRCC |
2.545700E-02 |
KIRP CIMP-VS-Unclassified PRCC |
4.462800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.37610034478541E-10 |
Normal-vs-N1 |
6.91724455492704E-12 |
Normal-vs-N2 |
2.863600E-02 |
N0-vs-N1 |
2.939200E-01 |
N0-vs-N2 |
4.335200E-01 |
N1-vs-N2 |
3.768600E-01 |
|
|